IgD于1965年首次被发现，与其他免疫球蛋白一样，它以分泌和膜的形式存在。IgD在血浆中的水平较低，平均浓度为30ug/ml。IgD大量存在于大多数人循环B淋巴细胞的表面膜上。IgD通过诱导T淋巴细胞上IgD受体的表达来增强体液免疫反应。 由经美国食品药品监督管理局要求的测试显示对HBsAg、抗-HCV、抗-HBc无反应且对抗-HIV 1和2呈阴性的血浆制备。 Ref: Coico RF, Siskind GW, Thorbecke GJ 1988. Immunol. Rev. 105:45. IgD was first identified in 1965, and like other immunoglobulins, exists as both secreted and membrane forms. Its level in plasma is low with a mean concentration of 30 ug/ml. IgD is present in large quantities on the surface membrane of a majority of human circulating B lymphocytes. IgD enhances humoral immune responses through its induction of IgD-receptor expression on T lymphocytes. Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA-required tests. Ref: Coico RF, Siskind GW, Thorbecke GJ 1988. Immunol. Rev. 105:45.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
免疫球蛋白D(IgD),人骨髓瘤血浆
CAS number：unknown molecular formula：
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | |
| molecular weight | - | Exact mass | ≥95%(SDS-PAGE) |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
